Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour's.

Trial Profile

Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour's.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jul 2010

At a glance

  • Drugs Carboplatin; Doxorubicin liposomal
  • Indications Cervical cancer; Endometrial cancer; Gynaecological cancer; Ovarian cancer; Uterine cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top